Eloxx Pharmaceuticals, Inc. Annual Return On Equity in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eloxx Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
  • Eloxx Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2023 was 248 %.
  • Eloxx Pharmaceuticals, Inc. annual Return On Equity for 2022 was 6.73K %.
  • Eloxx Pharmaceuticals, Inc. annual Return On Equity for 2021 was -270 %, a 40.4% decline from 2020.
  • Eloxx Pharmaceuticals, Inc. annual Return On Equity for 2020 was -192 %, a 61.8% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 6.73K +7K Jan 1, 2022 Dec 31, 2022
2021 -270 -77.7 -40.4% Jan 1, 2021 Dec 31, 2021
2020 -192 -73.5 -61.8% Jan 1, 2020 Dec 31, 2020
2019 -119 -6.45 -5.73% Jan 1, 2019 Dec 31, 2019
2018 -112 +189 +62.7% Jan 1, 2018 Dec 31, 2018
2017 -302 -28.8 -10.6% Jan 1, 2017 Dec 31, 2017
2016 -273 -203 -289% Jan 1, 2016 Dec 31, 2016
2015 -70.1 +8.24 +10.5% Jan 1, 2015 Dec 31, 2015
2014 -78.3 +138 +63.8% Jul 1, 2013 Jun 30, 2014
2013 -217 -79.8 -58.4% Jul 1, 2012 Jun 30, 2013
2012 -137 Jul 1, 2011 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.